UPDATE: Cowen Starts Intellia Therapeutics (NTLA) at Outperform
Tweet Send to a Friend
(Updated - January 31, 2022 5:31 AM EST)
Cowen analyst Joseph Thome initiates coverage on Intellia Therapeutics (NASDAQ: NTLA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cowen analyst Joseph Thome initiates coverage on Intellia Therapeutics (NASDAQ: NTLA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
